Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03147742
Brief Title: An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

First Submitted : May 8, 2017
First Submitted that Met QC Criteria : May 8, 2017
First Posted : May 10, 2017

Last Update Submitted that Met QC Criteria : July 27, 2021
Last Update Posted : July 28, 2021